Contineum Therapeutics, Inc.
CTNM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001855175
In the last 90 days, Contineum Therapeutics, Inc. insiders filed 0 open-market purchases and 7 sales; 102 institutions reported holding it in 13F filings for Q2 2026, worth $500.6M in total; HHLR Advisors (Hillhouse) is the only superinvestor holding it.
Superinvestors holding CTNM, Q2 2026
1 superinvestor reports holding Contineum Therapeutics, Inc. on Form 13F, worth $11.0M in total. Weight is Contineum Therapeutics, Inc.'s share of each 13F portfolio; actions compare shares with Q1 2026.
| Superinvestor | % of portfolio | Shares | Value | vs. previous quarter |
|---|---|---|---|---|
| HHLR Advisors (Hillhouse)Zhang Lei | 1.3% | 669,337 | $11.0M | Unchanged |
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of CTNM each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q2 2024
1 superinvestor holding at quarter end